Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from MannKind

The FDA Just Approved the First Inhaled Mealtime Insulin for Children

FDA approved Afrezza inhaled insulin for children ages 6+ in May 2026. No needle required at mealtimes. Here's what INHALE-1 found and what families should know.

Medical Daily · Jul 7

MannKind Wins FDA Approval for Afrezza in Children, Opening Pediatric Diabetes Market

MannKind (NASDAQ:MNKD) said the U.S. Food and Drug Administration has approved Afrezza for pediatric patients with diabetes ages 6 and older, expanding the inhaled mealtime insulin’s label into children and adolescents. Chief Executive Officer Michael Castagna called the decision “a truly historic

MarketBeat · May 31

MannKind, Backed By Blackstone, Expands Cardiorenal Focus With $360 Million Deal

MannKind Corporation (NASDAQ:MNKD) on Monday agreed to acquire scPharmaceuticals Inc. (NASDAQ:SCPH) for a deal value of up to approximately $360 million, or $5.35 per share.

Benzinga · Aug 25, 2025

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Biotech Stocks Investors Are Watching for Future Growth

A wide range of applications across several sectors, supportive government initiatives, rapid technological advancements, and shifting market dynamics position the biotechnology industry for robust long-term growth. Given the industry’s bright outlook, biotech stocks MannKind (MNKD), Illumina (ILMN), and TG Therapeutics (TGTX) could be ideal watchlist additions for potential growth. Read…

StockNews.com · Feb 2, 2024

MannKind Earnings Preview

MannKind (NASDAQ:MNKD) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that MannKind will report an earnings per share (EPS) of $-0.10.

Benzinga · May 4, 2022

4 Penny Stocks Insiders Are Buying: MannKind, Crexendo And More

Russian unemployment rate rose to a five-month high of 4.4% in January from 4.3% in the prior month. Investors, meanwhile, focused on some notable insider trades

Benzinga · Mar 2, 2022

Coverage From

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

United States

423,974 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.